Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cardiomyopathies | 2 | 2018 | 997 | 0.72 | Why? |
| Hepatic Encephalopathy | 1 | 2018 | 88 | 0.69 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.61 | Why? |
| Anesthetics | 1 | 2018 | 196 | 0.58 | Why? |
| Lypressin | 1 | 2012 | 9 | 0.51 | Why? |
| Surgical Procedures, Operative | 2 | 2019 | 2662 | 0.48 | Why? |
| Brain Death | 1 | 2012 | 146 | 0.42 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.39 | Why? |
| Hypotension | 1 | 2012 | 392 | 0.38 | Why? |
| Preoperative Care | 1 | 2019 | 1515 | 0.37 | Why? |
| Vasoconstrictor Agents | 1 | 2012 | 714 | 0.36 | Why? |
| Anesthesia | 1 | 2018 | 1236 | 0.35 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.34 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.31 | Why? |
| Xenon | 1 | 2018 | 27 | 0.19 | Why? |
| Embolism | 1 | 2020 | 136 | 0.19 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.18 | Why? |
| E2F1 Transcription Factor | 1 | 2017 | 11 | 0.17 | Why? |
| Craniotomy | 1 | 2018 | 123 | 0.17 | Why? |
| Organ Transplantation | 1 | 2012 | 2616 | 0.17 | Why? |
| Anesthetics, Intravenous | 1 | 2017 | 98 | 0.16 | Why? |
| Monitoring, Intraoperative | 1 | 2018 | 140 | 0.16 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.16 | Why? |
| Gene Silencing | 1 | 2017 | 213 | 0.15 | Why? |
| Abdomen | 1 | 2019 | 424 | 0.15 | Why? |
| Wakefulness | 1 | 2018 | 598 | 0.13 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.11 | Why? |
| Shock, Septic | 1 | 2021 | 1313 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.11 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.10 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.08 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Lung Diseases | 1 | 2019 | 2361 | 0.07 | Why? |
| Tissue Donors | 1 | 2012 | 1679 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.06 | Why? |
| Biology | 1 | 2021 | 71 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.05 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.04 | Why? |
| Humans | 12 | 2021 | 930598 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2017 | 381 | 0.04 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.04 | Why? |
| Pulmonary Ventilation | 1 | 2017 | 152 | 0.04 | Why? |
| Tissue Distribution | 1 | 2017 | 483 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Liposomes | 1 | 2017 | 334 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.03 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Feces | 1 | 2021 | 4235 | 0.02 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Aged | 1 | 2019 | 215776 | 0.01 | Why? |
| Male | 2 | 2021 | 367725 | 0.01 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.01 | Why? |
| Female | 1 | 2019 | 380317 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Animals | 1 | 2021 | 78931 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Piazza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(89)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_